Epidemiology and clinical aspects of the canal anal cancer

Date 29 June 2016
Event ESMO World Congress on Gastrointestinal Cancer 2016
Session ESMO World Congress on Gastrointestinal Cancer 2016 - Abstracts book
Presenter A. Zemmour
Citation Annals of Oncology (2016) 27 (2): 86-101. 10.1093/annonc/mdw201
Authors A. Zemmour1, B. Larbaoui2, D. Yekrou3, Z. Boudinar Fatima2, K. Rekai4
  • 1Oncology Department Emir Abdelkader Oran, Oran, Algeria, /
  • 2Oncology Department, Oran, Algeria, /
  • 3Oncology Department, Sidi Belabes, Algeria, /
  • 4Medical Oncology, EHSO Emir Abdelkader, Oran, Algeria, /


Cancers of the anal canal represent 1.5% of digestive cancers [1]. They predominate in women (sex ratio of 4 in France) and two thirds of patients over 65 years. The incidence is increasing and the age at diagnosis decreased. Over 90% of patients have locoregional disease diagnosis in the initial phase. Epidermoid carcinoma represent 90% of histological forms. We report the experience of Oncology Department (Emir AbdelKader Of Oran) in the canal anal management.